Talkin’ About a Resolution: Issues in the Push for Greater Transparency of Medicine PricesBrendan ShawJan 20, 20201 min readArticle published in Pharmacoeconomics 20 January 2020 on transparency of medicine prices can be found here.
Costs and benefits: how has the Pharmaceutical Benefits Scheme contributed to Australia over the last quarter century?
Recognising rebates: the role of pharmaceutical companies in funding UK and Australian pharmaceutical schemes
Comments